A results-driven and strategic C-level executive with over 25 years of international experience in the life sciences industry, dedicated to improving care and outcomes for cancer patients. Proven track record of building and leading high-performing teams, with extensive expertise in the development, clinical validation, regulatory approval, and launch of innovative molecular diagnostic products and services in the genomics arena. Career highlights include successful fundraising, establishing and scaling operations, building commercial organizations, introducing novel molecular solutions to US and European clinical and pharma markets, gaining guideline inclusion, building brand recognition, capturing market share, securing reimbursement, driving revenue growth, and increasing shareholder value. Passionate about integrating cutting-edge diagnostics to enhance early detection, personalized treatment, and overall patient care in oncology.
Listed skills include Oncology, Biotechnology, Medical Devices, Lifesciences, and 24 others.